228 related articles for article (PubMed ID: 29109148)
21. Cloning and characterization of a novel human histone deacetylase, HDAC8.
Buggy JJ; Sideris ML; Mak P; Lorimer DD; McIntosh B; Clark JM
Biochem J; 2000 Aug; 350 Pt 1(Pt 1):199-205. PubMed ID: 10926844
[TBL] [Abstract][Full Text] [Related]
22. Hydroxamic Acid-Modified Peptide Library Provides Insights into the Molecular Basis for the Substrate Selectivity of HDAC Corepressor Complexes.
Archibald LJ; Brown EA; Millard CJ; Watson PJ; Robertson NS; Wang S; Schwabe JWR; Jamieson AG
ACS Chem Biol; 2022 Sep; 17(9):2572-2582. PubMed ID: 35973051
[TBL] [Abstract][Full Text] [Related]
23. Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor.
Hu E; Chen Z; Fredrickson T; Zhu Y; Kirkpatrick R; Zhang GF; Johanson K; Sung CM; Liu R; Winkler J
J Biol Chem; 2000 May; 275(20):15254-64. PubMed ID: 10748112
[TBL] [Abstract][Full Text] [Related]
24. Design of Potent Panobinostat Histone Deacetylase Inhibitor Derivatives: Molecular Considerations for Enhanced Isozyme Selectivity between HDAC2 and HDAC8.
Stoddard SV; May XA; Rivas F; Dodson K; Vijayan S; Adhika S; Parker K; Watkins DL
Mol Inform; 2019 Mar; 38(3):e1800080. PubMed ID: 30369061
[TBL] [Abstract][Full Text] [Related]
25. The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.
Negmeldin AT; Knoff JR; Pflum MKH
Eur J Med Chem; 2018 Jan; 143():1790-1806. PubMed ID: 29150330
[TBL] [Abstract][Full Text] [Related]
26. Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases.
Borra MT; Langer MR; Slama JT; Denu JM
Biochemistry; 2004 Aug; 43(30):9877-87. PubMed ID: 15274642
[TBL] [Abstract][Full Text] [Related]
27. Lysine Deacetylase Substrate Selectivity: A Dynamic Ionic Interaction Specific to KDAC8.
Toro TB; Swanier JS; Bezue JA; Broussard CG; Watt TJ
Biochemistry; 2021 Aug; 60(33):2524-2536. PubMed ID: 34357750
[TBL] [Abstract][Full Text] [Related]
28. Histone deacetylase 8 suppresses osteogenic differentiation of bone marrow stromal cells by inhibiting histone H3K9 acetylation and RUNX2 activity.
Fu Y; Zhang P; Ge J; Cheng J; Dong W; Yuan H; Du Y; Yang M; Sun R; Jiang H
Int J Biochem Cell Biol; 2014 Sep; 54():68-77. PubMed ID: 25019367
[TBL] [Abstract][Full Text] [Related]
29. Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants.
Marek M; Shaik TB; Heimburg T; Chakrabarti A; Lancelot J; Ramos-Morales E; Da Veiga C; Kalinin D; Melesina J; Robaa D; Schmidtkunz K; Suzuki T; Holl R; Ennifar E; Pierce RJ; Jung M; Sippl W; Romier C
J Med Chem; 2018 Nov; 61(22):10000-10016. PubMed ID: 30347148
[TBL] [Abstract][Full Text] [Related]
30. Structural and Functional Influence of the Glycine-Rich Loop G
Porter NJ; Christianson NH; Decroos C; Christianson DW
Biochemistry; 2016 Dec; 55(48):6718-6729. PubMed ID: 27933794
[TBL] [Abstract][Full Text] [Related]
31. Novel structural insights into class I and II histone deacetylases.
Ficner R
Curr Top Med Chem; 2009; 9(3):235-40. PubMed ID: 19355988
[TBL] [Abstract][Full Text] [Related]
32. Loop interactions and dynamics tune the enzymatic activity of the human histone deacetylase 8.
Kunze MB; Wright DW; Werbeck ND; Kirkpatrick J; Coveney PV; Hansen DF
J Am Chem Soc; 2013 Nov; 135(47):17862-8. PubMed ID: 24171457
[TBL] [Abstract][Full Text] [Related]
33. Preparation of a new construct of human histone deacetylase 8 for the crystallization of enzyme-inhibitor complexes.
Porter NJ; Christianson DW
Methods Enzymol; 2019; 626():561-585. PubMed ID: 31606091
[TBL] [Abstract][Full Text] [Related]
34. Histone deacetylase 8 protects human proximal tubular epithelial cells from hypoxia-mimetic cobalt- and hypoxia/reoxygenation-induced mitochondrial fission and cytotoxicity.
Ha SD; Solomon O; Akbari M; Sener A; Kim SO
Sci Rep; 2018 Jul; 8(1):11332. PubMed ID: 30054507
[TBL] [Abstract][Full Text] [Related]
35. Factors affecting the substrate specificity of histone deacetylases.
Riester D; Hildmann C; Grünewald S; Beckers T; Schwienhorst A
Biochem Biophys Res Commun; 2007 Jun; 357(2):439-45. PubMed ID: 17428445
[TBL] [Abstract][Full Text] [Related]
36. Acetyl-lysine analog peptides as mechanistic probes of protein deacetylases.
Smith BC; Denu JM
J Biol Chem; 2007 Dec; 282(51):37256-65. PubMed ID: 17951578
[TBL] [Abstract][Full Text] [Related]
37. Structure of 'linkerless' hydroxamic acid inhibitor-HDAC8 complex confirms the formation of an isoform-specific subpocket.
Tabackman AA; Frankson R; Marsan ES; Perry K; Cole KE
J Struct Biol; 2016 Sep; 195(3):373-378. PubMed ID: 27374062
[TBL] [Abstract][Full Text] [Related]
38. An unbiased approach to identify endogenous substrates of "histone" deacetylase 8.
Olson DE; Udeshi ND; Wolfson NA; Pitcairn CA; Sullivan ED; Jaffe JD; Svinkina T; Natoli T; Lu X; Paulk J; McCarren P; Wagner FF; Barker D; Howe E; Lazzaro F; Gale JP; Zhang YL; Subramanian A; Fierke CA; Carr SA; Holson EB
ACS Chem Biol; 2014 Oct; 9(10):2210-6. PubMed ID: 25089360
[TBL] [Abstract][Full Text] [Related]
39. Kinetically selective and potent inhibitors of HDAC8.
Schweipert M; Jänsch N; Sugiarto WO; Meyer-Almes FJ
Biol Chem; 2019 May; 400(6):733-743. PubMed ID: 30521473
[TBL] [Abstract][Full Text] [Related]
40. Docking of hydroxamic acids into HDAC1 and HDAC8: a rationalization of activity trends and selectivities.
Ortore G; Di Colo F; Martinelli A
J Chem Inf Model; 2009 Dec; 49(12):2774-85. PubMed ID: 19947584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
